3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Terminated
1
Sponsor Class
NIH
8
OTHER
5
OTHER_GOV
1
NETWORK
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
66
Neoplasms
49
Stomach Neoplasms
45
Colorectal Neoplasms
42
Carcinoma, Non-Small-Cell Lung
37
Lung Neoplasms
30
Uterine Cervical Neoplasms
28
Rectal Neoplasms
28
Carcinoma, Hepatocellular
25
Prostatic Neoplasms
24
Recurrence
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Ovarian Neoplasms
18
Neoplasm Metastasis
16
Colonic Neoplasms
16
Esophageal Neoplasms
15
Urinary Bladder Neoplasms
14
Thyroid Neoplasms
14
Pancreatic Neoplasms
14
Nasopharyngeal Carcinoma
14
Leukemia, Myeloid, Acute
13
Head and Neck Neoplasms
13
Small Cell Lung Carcinoma
11
Papillomavirus Infections
11
Multiple Myeloma
11
Motor Activity
11
Melanoma
11
Lymphoma
11
Sarcoma
10
Lymphoma, Non-Hodgkin
10
Interventions
Observation
1
Erlotinib Hydrochloride
1
DMAC2L protein, human
1
Celecoxib
1
26S proteasome non-ATPase regulatory subunit 13
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
OTHER_GOV
×
Tongue Neoplasms
×
Clear all
NCT02748707
2022-04-28
ERLO-XIB
Tata Memorial Hospital
Phase 2
Unknown
64 enrolled